Amplo Biotechnology
PrivateLast Round
Grant
Jan 30, 2025
Total Funding Raised
$2.2M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Amplo Biotechnology is a biotechnology company that develops adeno-associated virus (AAV) gene therapies for neuromuscular junction disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amplo Biotechnology Comparables
Compare Amplo Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Atamyo Therapeutics | 83% | |
| Kinea Bio, Inc. | 79% | |
| Beijing Genecradle Therapeutics Co., Ltd. | 72% |
Amplo Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 30, 2025 | ||||
| Grant | May 31, 2023 | ||||
| Seed | Oct 6, 2021 |
Amplo Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| California Institute for Regenerative Medicine | Grant |
| SeedFolio | Seed |
| BioBrit | Seed |
| Casdin Capital | Seed |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 41% MoM.
- Jan 29, 2026
Monthly visitors increased 75% MoM.
Amplo Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Amplo Biotechnology's valuation, stock price, and market status.
Is Amplo Biotechnology a public or private company?
Amplo Biotechnology is a private company.
What is the current stock price of Amplo Biotechnology?
Amplo Biotechnology is a private company with no public stock price. Caplight tracks Amplo Biotechnology's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Amplo Biotechnology worth (valuation)?
Valuation information for Amplo Biotechnology is not publicly available.
Can I buy Amplo Biotechnology stock?
Amplo Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Amplo Biotechnology's last funding round?
Amplo Biotechnology's most recent funding round was Grant on January 30, 2025.
Who are the main investors in Amplo Biotechnology?
Key investors in Amplo Biotechnology include BioBrit.
Will Amplo Biotechnology IPO soon?
No public IPO plans have been announced for Amplo Biotechnology.
How can I track Amplo Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Amplo Biotechnology's secondary market activity and sign up for updates.